国产成人av综合色-国产成人a人亚洲精品无码-国产成人a亚洲精v品无码-国产成人a在线观看视频免费-国产成人a在线观看视频免费-国产成人精品123区免费视频

China's First Litigation Case of Pharmaceutical Patent Linkage —— Chugai Pharmaceutical Co., Ltd. vs. Wenzhou Haihe Pharmaceutical Co., Ltd., Case of Dispute over Identifying Whether to Fall into Protection Scope of Patent Rights

May 6, 2023

Case Brief

In light of Article 76.1 of the Chinese Patent Law, Chugai Pharmaceutical Co., Ltd. filed a lawsuit on pharmaceutical patent linkage with the Beijing Intellectual Property Court, requesting to identify that the technical solution of the generic drug "Eldecalcitol Soft Capsules" of Wenzhou Haihe falls into the protection scope of patent claims involved. The court of first instance ordered to reject the litigation claims filed by Chugai Co., Ltd. Chugai Pharmaceutical Co., Ltd. was dissatisfied and filed an appeal. The Supreme People's Court held in the second instance that, Wenzhou Haihe failed to make any statement on the claim with the maximum protection scope and to notify Chugai Pharmaceutical Co., Ltd., the marketing authorization holder, of the statement and the statement basis in a timely manner, and such failure was inappropriate and should be criticized; as for the determination of whether the technical solution of generic drug would fall into the protection scope of patent claims, in principle, comparison and evaluation should be conducted based on the application files submitted by the generic drug applicant; upon comparison, the technical solution of generic drug involved did not fall into the protection scope of patent claims. It was therefore ordered to reject the appeal and uphold the original sentence.

Typical Significance

The present case is China's first litigation case of pharmaceutical patent linkage. China's pharmaceutical patent linkage system is preliminarily established and is still in the exploration phase. The judgment of the present case embodies legislative-purpose-compliant exploratory legal application regarding new issues incurred in the initial practice phase of pharmaceutical patent linkage system and receives considerable attention and widespread praise from the Chinese and foreign media and pharmaceutical communities. CMG has promptly reported the present case, which is selected as one of the "Top Ten Nomination Cases for Promoting the Process of Rule of Law in the New Era in 2022".

(Source of case: Supreme People's Court of the People's Republic of China)

 

Keywords

主站蜘蛛池模板: 麻豆蜜桃av蜜臀av色欲av | 日韩欧美在线视频观看 | 久久夏同学国产免费观看 | 五月天激情电影 | 九月色婷婷 | 亚洲开心网| 久久都是精品 | 亚洲日本久久一区二区va | 好吊色欧美一区二区三区四区 | 亚洲国产欧美在线人成北岛玲 | 狠狠亚洲婷婷综合色香五月 | 香蕉久久精品 | 欧美人妻一区二区三区 | 欧美午夜精品 | 国产亚洲精品久久777777 | 色吧首页dvd| 久久亚洲最大成人网4438 | 国产精彩视频在线 | 无码h黄肉3d动漫在线观看 | 天天综合天天做 | 日本丰满少妇裸体自慰 | 999精品国产人妻无码系列久久 | 国产成人精品福利网站在线观看 | 久久综合久久久久 | 2级毛片 | 国产精品美女www爽爽爽视频 | 欧美一区精品二区三区 | 精品九九人人做人人爱 | 亚洲欧美v国产蜜芽tv | 亚洲欧美日韩中文字幕久久 | 精品久久人妻av中文字幕 | 国产激爽大片高清在线观看 | 国产又黄又爽又猛免费视频播放 | 日韩在线高清视频 | 成人偷拍自拍 | 99爱在线视频这里只有精品 | 精品人妻人人做人人爽夜夜爽 | 激情se | 精品免费国产一区二区三区四区 | 国产成+人欧美+综合在线观看 | 欧美国产人妖另类色视频 |